BR0212447A - Uso de hcg e lh na hiperestimulação ovariana controlada - Google Patents

Uso de hcg e lh na hiperestimulação ovariana controlada

Info

Publication number
BR0212447A
BR0212447A BR0212447-5A BR0212447A BR0212447A BR 0212447 A BR0212447 A BR 0212447A BR 0212447 A BR0212447 A BR 0212447A BR 0212447 A BR0212447 A BR 0212447A
Authority
BR
Brazil
Prior art keywords
hcg
ovarian hyperstimulation
controlled ovarian
rates
controlled
Prior art date
Application number
BR0212447-5A
Other languages
English (en)
Inventor
Yves Menezo
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8182262&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0212447(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of BR0212447A publication Critical patent/BR0212447A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/11—Gonadotropin; related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/13—Luteinizing hormone-releasing hormone; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

"USO DE hCG E LH NA HIPERESTIMULAçãO OVARIANA CONTROLADA". A invenção proporciona um protocolo que leva a taxas aperfeiçoadas de implante de embrião e/ou taxas diminuídas de aborto, no qual hCG ou LH, ou um análogo dos mesmos, é administrado durante a fase folicular.
BR0212447-5A 2001-09-12 2002-09-12 Uso de hcg e lh na hiperestimulação ovariana controlada BR0212447A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01307758 2001-09-12
PCT/GB2002/004167 WO2003022303A2 (en) 2001-09-12 2002-09-12 Use of hcg and lh in controlled ovarian hyperstimulation

Publications (1)

Publication Number Publication Date
BR0212447A true BR0212447A (pt) 2004-08-17

Family

ID=8182262

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0212447-5A BR0212447A (pt) 2001-09-12 2002-09-12 Uso de hcg e lh na hiperestimulação ovariana controlada

Country Status (27)

Country Link
US (1) US7402558B2 (pt)
EP (1) EP1425033B1 (pt)
JP (1) JP2005501919A (pt)
KR (1) KR20040032952A (pt)
CN (1) CN100376289C (pt)
AR (1) AR036593A1 (pt)
AT (1) ATE489964T1 (pt)
BR (1) BR0212447A (pt)
CA (1) CA2457851A1 (pt)
CY (1) CY1110991T1 (pt)
DE (1) DE60238490D1 (pt)
DK (1) DK1425033T3 (pt)
EA (1) EA009279B1 (pt)
ES (1) ES2356895T3 (pt)
HK (1) HK1067865A1 (pt)
HR (1) HRP20040086A2 (pt)
IL (1) IL160782A0 (pt)
ME (1) MEP38708A (pt)
MX (1) MXPA04002257A (pt)
NO (1) NO327153B1 (pt)
PL (1) PL369021A1 (pt)
PT (1) PT1425033E (pt)
SI (1) SI1425033T1 (pt)
UA (1) UA82052C2 (pt)
WO (1) WO2003022303A2 (pt)
YU (1) YU21104A (pt)
ZA (1) ZA200400781B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040248784A1 (en) * 2003-06-03 2004-12-09 Marco Filicori Unitary combinations of FSH and hCG
GB0723882D0 (en) * 2007-12-07 2008-01-23 Univ Leicester Methods for the detection of a threatened miscarriage
JP2014520869A (ja) 2011-07-18 2014-08-25 アルツ バイオロジクス アクティーゼルスカブ 長期作用性で生物学的活性が有る黄体形成ホルモン（ｌｈ）化合物
EP2968391A1 (en) 2013-03-13 2016-01-20 Moderna Therapeutics, Inc. Long-lived polynucleotide molecules
PL3037101T3 (pl) * 2014-12-22 2019-06-28 Ferring B.V. Terapia antagonistą receptora oksytocyny w fazie lutealnej w celu implantacji i uzyskania ciąży u kobiet poddawanych technikom wspomaganego rozrodu
AU2016223496B2 (en) * 2015-02-26 2021-09-09 Ferring B.V. Methods of treating infertility
US11185569B2 (en) * 2016-05-04 2021-11-30 University Of Cincinnati ActRIIB:Fc to treat infertility in females
KR20210079276A (ko) * 2018-10-17 2021-06-29 훼링 비.브이. 제어된 난소 자극을 위한 조성물 및 방법
CN110041436A (zh) * 2019-04-28 2019-07-23 广州威生医药科技有限公司 长效重组fsh融合蛋白在母猪批次化生产中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4589402A (en) 1984-07-26 1986-05-20 Serono Laboratories, Inc. Method of in vitro fertilization
US5705478A (en) * 1989-02-21 1998-01-06 Washington University Covalently linked β subunits of the glycoprotein hormones as antagonists
FR2744367B1 (fr) * 1996-02-02 1999-07-09 Emperaire Jean Claude Medicaments pour le declenchement de l'ovulation
AU8727798A (en) * 1997-06-20 1999-01-04 Akzo Nobel N.V. Gonadotropin releasing hormone antagonist
ZA987497B (en) * 1997-09-08 1999-02-23 Akzo Nobel Nv Expression of gonadotropins in dictyostelium
US6090848A (en) * 1997-12-01 2000-07-18 Sigma-Tau Healthscience S.P.A. Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans
EP1156822B1 (en) * 1999-02-24 2006-02-08 Novo Nordisk A/S Iin vitro method for synchronisation of oocyte maturation
DK1176976T4 (en) * 1999-05-07 2015-11-02 Serono Lab Use of LH administered mid- or senfollikelfase for the treatment of anovulatory women
BR0107881A (pt) * 2000-01-27 2003-04-01 Applied Research Systems Uso de fsh tratamento de infertilidade
US6953774B2 (en) * 2000-08-11 2005-10-11 Applied Research Systems Ars Holding N.V. Methods of inducing ovulation

Also Published As

Publication number Publication date
PT1425033E (pt) 2010-12-29
IL160782A0 (en) 2004-08-31
JP2005501919A (ja) 2005-01-20
CN1553810A (zh) 2004-12-08
ATE489964T1 (de) 2010-12-15
NO327153B1 (no) 2009-05-04
ES2356895T3 (es) 2011-04-14
KR20040032952A (ko) 2004-04-17
EA200400426A1 (ru) 2004-08-26
ZA200400781B (en) 2005-04-26
DE60238490D1 (de) 2011-01-13
US20050020489A1 (en) 2005-01-27
MXPA04002257A (es) 2004-07-23
EA009279B1 (ru) 2007-12-28
WO2003022303A2 (en) 2003-03-20
MEP38708A (en) 2011-02-10
YU21104A (sh) 2006-08-17
EP1425033B1 (en) 2010-12-01
SI1425033T1 (sl) 2011-01-31
HRP20040086A2 (en) 2004-12-31
EP1425033A2 (en) 2004-06-09
CN100376289C (zh) 2008-03-26
HK1067865A1 (en) 2005-04-22
WO2003022303A3 (en) 2003-12-18
AR036593A1 (es) 2004-09-22
UA82052C2 (uk) 2008-03-11
PL369021A1 (en) 2005-04-18
NO20040962L (no) 2004-03-05
US7402558B2 (en) 2008-07-22
DK1425033T3 (da) 2011-01-10
CA2457851A1 (en) 2003-03-20
CY1110991T1 (el) 2015-06-11

Similar Documents

Publication Publication Date Title
BR0212429A (pt) Uso de hcg na hiperestimulação ovariana controlada
BR0213358A (pt) Uso de flibanserina
NO20031018D0 (no) Oksymorfonpreparater med kontrollert frigivelse
DE60126321D1 (de) Gelsystem zur ocularen verabreichung von arzneimitteln
ATE298233T1 (de) Kosmetische und pharmazeutische öl-in-wasser- emulsionen von polyethermodifizierten polysiloxanen
FR2765794B1 (fr) Dispositif d'eveinage notamment pour endoeveinage
SE0100901D0 (sv) New composition
BR0005390A (pt) Dispositivo amortecedor
DE60115418D1 (de) Mikroinfusionsvorrichtung zur verabreichung von medikamenten
HUP0303656A3 (en) Modulators of bruton's tyrosine kinase, their identification and use
ITMI20001463A0 (it) Dispositivo per il controllo della stabilita' dinamica di un veicolo industriale.
BR9913457A (pt) Neuroproteção
DE69818026D1 (de) Wässrige suspension zur nasalen verabreichung von loteprednol
HK1067865A1 (en) Use of hcg and lh in controlled ovarian hyperstimulation
ZA200108130B (en) Treatment of pulmonary hypertension.
CY1110487T1 (el) Χρηση της lh σε ελεγχομενη υπερδιεγερση των ωοθηκων
BR0213684A (pt) Uso de antagonistas do receptor de endotelina para o tratamento de doenças tumorìgenas
BR0206697A (pt) Fio tingido espacialmente
BR9909357A (pt) Solução ou suspensão de mirtazapina em mistura com água, formulação farmacêutica compreendendo mirtazapina, e, uso de mirtazapina
BR0207066A (pt) Derivados do 2h-1-benzopirano - processos para sua preparação e composições farmacêuticas a partir deles
BR0016941A (pt) Derivados de aminometil-fenil-ciclohexanona
WO2002024181A3 (en) The use of melatonin for induction of general anesthesia
FR2804885B1 (fr) Nouvelle famille de compositions a base d'alkylpolyglycosides et de dimerdiol, notamment utiles pour la preparation d'emulsions huile-dans-eau vaporisables
BR0114459A (pt) Derivados substituìdos de 5-amino-1-penten-3-ol substituidos
BR0206918A (pt) Uso de iloperidona

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: LABORATOIRES SERONO S.A. (CH)

Free format text: TRANSFERIDO DE: APPLIED RESEARCH SYSTEMS ARS HOLDING N.V.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUI DADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2108 DE 31/05/2011.